101 related articles for article (PubMed ID: 23900762)
1. Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya.
Huchko MJ; Leslie H; Sneden J; Maloba M; Abdulrahim N; Bukusi EA; Cohen CR
Int J Cancer; 2014 Feb; 134(3):740-5. PubMed ID: 23900762
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya.
Huchko MJ; Sneden J; Sawaya G; Smith-McCune K; Maloba M; Abdulrahim N; Bukusi EA; Cohen CR
Int J Cancer; 2015 Jan; 136(2):392-8. PubMed ID: 24889387
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with recurrence of cervical intraepithelial neoplasia 2+ after treatment among HIV-infected women in Western Kenya.
Huchko MJ; Leslie H; Maloba M; Bukusi EA; Cohen CR
J Acquir Immune Defic Syndr; 2014 Jun; 66(2):188-92. PubMed ID: 24662299
[TBL] [Abstract][Full Text] [Related]
4. Precancerous lesions of cervix among women infected with HIV in Referral Hospitals of Amhara Region, Northwest Ethiopia: a cross sectional study.
Kassa LS; Dile WM; Zenebe GK; Berta AM
Afr Health Sci; 2019 Mar; 19(1):1695-1704. PubMed ID: 31149000
[TBL] [Abstract][Full Text] [Related]
5. Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
Omenge Orang'o E; Liu T; Christoffersen-Deb A; Itsura P; Oguda J; Washington S; Chumba D; Pisharodi L; Cu-Uvin S; Rositch AF
AIDS; 2017 Jan; 31(2):233-240. PubMed ID: 28002084
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of precancerous cervical cancer lesion among HIV-infected women in southern Ethiopia: a cross-sectional study.
Gedefaw A; Astatkie A; Tessema GA
PLoS One; 2013; 8(12):e84519. PubMed ID: 24376818
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
8. Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population.
Bekolo CE; O'Bryan G; Tchago FE; Nangue C; Bekoule PS; Kollo B
PLoS One; 2016; 11(2):e0149152. PubMed ID: 26866371
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral Therapy and Detection of High-grade Cervical Intraepithelial Neoplasia (CIN2+) at Post-CIN Management Follow-up Among Women Living With Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis.
Atemnkeng N; Aji AD; de Sanjose S; Mayaud P; Kelly H
Clin Infect Dis; 2020 Dec; 71(10):e540-e548. PubMed ID: 32162657
[TBL] [Abstract][Full Text] [Related]
10. The relationship between HIV infection and cervical intraepithelial neoplasia among women attending two family planning clinics in Nairobi, Kenya.
Maggwa BN; Hunter DJ; Mbugua S; Tukei P; Mati JK
AIDS; 1993 May; 7(5):733-8. PubMed ID: 8318180
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of Cervical Squamous Intraepithelial Lesions in HIV Infected Women in Kenya: a cross-Sectional Study.
Memiah P; Makokha V; Mbuthia W; Kiiru GW; Agbor S; Odhiambo F; Ojoo S; Mbizo J; Muhula S; Mahasi G; Biadgilign S
Afr J Reprod Health; 2015 Mar; 19(1):133-9. PubMed ID: 26103703
[TBL] [Abstract][Full Text] [Related]
12. Precancerous lesion determinants in women attending cervical cancer screening at public health facilities in North Shoa Zone, Amhara, Ethiopia: an unmatched case-control study.
Teklehaimanot DA; Mekuria AD; Dadi AF; Derseh BT
BMC Womens Health; 2024 May; 24(1):271. PubMed ID: 38702683
[TBL] [Abstract][Full Text] [Related]
13. DETERMINANT FACTORS OF VISUAL INSPECTION WITH ACETIC ACID (VIA) POSITIVE LESIONS AMONG HIV POSITIVE WOMEN IN MEKELLE HOSPITAL, NORTHERN ETHIOPIA: A CASE CONTROL STUDY.
Gessesse Z; Tadesse Z; Alemayehu M; Hiruye A; Getachew Y; Derbew M; Mariam DH; Mammo D; Eva K; Yebyo H; Michael HG
Ethiop Med J; 2015 Jul; Suppl 2():17-24. PubMed ID: 26591279
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and predictors of cervical cancer screening among HIV-positive women in rural western Uganda: insights from the health-belief model.
Vigneshwaran E; Goruntla N; Bommireddy BR; Mantargi MJS; Mopuri B; Thammisetty DP; Veerabhadrappa KV; Bukke SPN
BMC Cancer; 2023 Dec; 23(1):1216. PubMed ID: 38066496
[TBL] [Abstract][Full Text] [Related]
15. Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapy.
Chung MH; McKenzie KP; De Vuyst H; Richardson BA; Rana F; Pamnani R; Njoroge JW; Nyongesa-Malava E; Sakr SR; John-Stewart GC; Mugo NR
AIDS; 2013 Nov; 27(18):2909-19. PubMed ID: 23842133
[TBL] [Abstract][Full Text] [Related]
16. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
Heard I; Potard V; Costagliola D
Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women.
Anastos K; Hoover DR; Burk RD; Cajigas A; Shi Q; Singh DK; Cohen MH; Mutimura E; Sturgis C; Banzhaf WC; Castle PE
PLoS One; 2010 Oct; 5(10):e13525. PubMed ID: 20976000
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer and precancerous cervical lesions detected using visual inspection with acetic acid at Livingstone Teaching Hospital.
Hayumbu V; Hangoma J; Hamooya BM; Malumani M; Masenga SK
Pan Afr Med J; 2021; 40():235. PubMed ID: 35178146
[TBL] [Abstract][Full Text] [Related]
19. Natural History of Cervical Intraepithelial Neoplasia-2 in HIV-Positive Women of Reproductive Age.
Colie C; Michel KG; Massad LS; Wang C; DʼSouza G; Rahangdale L; Flowers L; Milam J; Palefsky JM; Minkoff H; Strickler HD; Kassaye SG
J Acquir Immune Defic Syndr; 2018 Dec; 79(5):573-579. PubMed ID: 30272635
[TBL] [Abstract][Full Text] [Related]
20. Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study.
Clifford GM; Franceschi S; Keiser O; Schöni-Affolter F; Lise M; Dehler S; Levi F; Mousavi M; Bouchardy C; Wolfensberger A; Darling KE; Staehelin C; Bertisch B; Kuenzli E; Bernasconi E; Pawlita M; Egger M;
Int J Cancer; 2016 Apr; 138(7):1732-40. PubMed ID: 26537763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
